Our pooled analysis of 19 studies indicated that VAV3 may have tumor-suppressive properties, as it is downregulated in kidney cancers, and that higher VAV3 mRNA expression levels were associated with better survival outcomes in patients with RCC. The gene discussed is VAV3; the disease is kidney cancer.